Molecular imaging reveals unique degenerative changes in experimental glaucoma

Lmamura K., Onoe H., Shimazawa M., Nozaki S., Wada Y., Kato K., Nakajima H., Mizuma H., Onoe K., Taniguchi T., Sasaoka M., Hara H., Tanaka S., Araie M., Watanabe Y.

2009
NeuroReport

View publication

Therapeutic Area

Glaucoma
Categories

Preclinical development

Affiliations

Department of Systems Life Engineering, Maebashi Institute of Technology, Maebashi-shi, Japan; Department of Physiology, Osaka City University Graduate, School of Medicine, Osaka, Japan; Laboratory of Visual Neurocomputing, Brain Science Institute, RIKEN, Saitama, Japan; Molecular Imaging Research Program, RIKEN, Kobe, Japan; Department of Biofunctional Evaluation, Molecular Pharmacology, Gifu Pharmaceutical University, Mitahora-higashi, Gifu, Japan; Glaucoma Group, Research and Development Center, Santen Pharmaceutical Co. Ltd., Ikoma, Japan; Department of Ophthalmology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan; Department of Systems Life Engineering, Maebashi Institute of Technology, 460-1 Kamisadori-machi, Maebashi-shi, Gunma 371-0816, Japan

Related Publications

Assessment of Brain-Derived Neurotrophic Factor on Retinal Structure and Visual Function in Rodent Models of Optic Nerve Crush

Taniguchi T.; Sharif N.A.; Ota T.; Farjo R.A.; Rausch R.

24-Hour Evaluation of the Effectiveness and Tolerability of Preservative-Free Tafluprost-Timolol Fixed Combination in Open-Angle Glaucoma or Ocular Hypertensive Patients Previously Treated with Preserved Latanoprost

Oddone F, Tanga L, Giammaria S, Sabbatini L, Strianese A, Ferrazza M, Rossetti LM

MicroRNA profile of extracellular vesicles released by Müller glial cells

Lamb W D.B.; Eastlake K.; Luis J.; Sharif N.A. ; Khaw P. T.; Limb G. A.